Crossmark

Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan

Crossref DOI link: https://doi.org/10.1038/s41598-021-84853-y

Published Online: 2021-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liao, Chia-Te

Hsieh, Tung-Han

Shih, Chia-Yin

Liu, Ping-Yen

Wang, Jung-Der
Funding

Funding for this research was provided by:

National Health Research Institutes (NHRI-108A1-EMCO-02191910)

National Health Research Institutes (NHRI-109A1-EMCO-02202210)

Ministry of Science and Technology, Taiwan (MOST 108-2627-M-006-001)

Ministry of Science and Technology, Taiwan (MOST 107-2627-M-006-007)
License Information

Text and Data Mining valid from 2021-03-10

Version of Record valid from 2021-03-10
More Information

Article History

Received: 3 October 2020

Accepted: 15 February 2021

First Online: 10 March 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below